Quantcast

Latest Bevacizumab Stories

2012-05-22 00:03:26

VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with bevacizumab (Avastin). If validated, this discovery could be an important step towards personalized medicine and patient-tailored use of this important cancer drug. Diether Lambrechts (VIB — KU Leuven) said "in two large clinical studies with patients with advanced stages of pancreas and kidney cancer a variant in...

2012-05-08 10:42:47

Clinical studies in retinal diseases scheduled to begin in second half 2012 Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced that positive data from a study of aganirsen (GS-101, eye drops) in a nonhuman primate model of choroidal neovascularization has been presented at the 2012 ARVO Annual Meeting in Fort Lauderdale, Florida. Topical administration of aganirsen was found to inhibit neovascular growth and leakage in...

2012-05-08 05:24:36

(Ivanhoe Newswire) — Looking into the future of medicine! Researchers may have found new hope for sufferers of macular regeneration facing blindness. While injectable drugs called angiogenesis inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof. For the first time researchers report that an oral nutriceutical, used on a last resort basis, rapidly restores vision to...

2012-05-07 13:26:18

Study shows Avastin has similar effect to Lucentis in treating most common cause of blindness in the developed world The one year results from a study into whether two drug treatments (Lucentis and Avastin), are equally effective in treating neovascular or wet age-related macular degeneration (wet AMD), have been reported today at an international research meeting in Fort Lauderdale, Florida. Wet AMD is a common cause of loss of vision in older people. In the UK, around 70 per cent of...

2012-05-07 09:16:34

Nutriceutical offers hope to those facing blindness There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof. For the first time researchers report that...

2012-05-01 21:25:08

American Health Assistance Foundation Calls for Greater Investment in Research to Halt Eye Disease This week, the second-year results of an important clinical trial on age-related macular degeneration (AMD), known as the Comparison of AMD Treatments Trials (or CATT), were published in the journal Ophthalmology. Researchers found that two drugs known as Avastin (bevacizumab) and Lucentis (ranibizumab), commonly used to treat the wet form of AMD, were similarly effective in maintaining...

2012-04-30 15:59:49

Year 2 results corroborate initial findings that 2 medications provide strikingly similar results Two drugs commonly used to treat age-related macular degeneration (AMD) yield similar improvements in vision for patients receiving treatments on a monthly or as-needed basis, according to a study from researchers at the Center for Preventive Ophthalmology and Biostatistics (CPOB) at the Perelman School of Medicine at the University of Pennsylvania. The year-two results of the Comparison of...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related